Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart. 31P-NMR studies. 1984

V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks

Fluxes catalyzed by soluble creatine kinase (MM) in equilibrium in vitro and by the creatine kinase system in perfused rat hearts were studied by 31P-NMR saturation transfer method. It was found that in vitro both forward and reverse fluxes through creatine kinase at equilibrium were almost equal and very stable to changes in phosphocreatine/creatine ratio (from 0.2 to 3.0) as well as to changes in pH (from 7.4 to 6.5 or 8.1), free Mg2+ concentration and 2-fold decrease of total adenine nucleotides and creatine pools (from 8.0 to 4.0 mM and from 30 to 14 mM, respectively). In the rat hearts perfused by the Langendorff method the creatine kinase-catalyzed flux from phosphocreatine to ATP was increased by 50% when oxygen consumption grew from 8 to 55 mumol/min per g of dry wt. due to transition from rest to high workload. These changes could not be exclusively explained on the basis of the equilibrium model by activation of heart creatine kinase due to some decrease in [phosphocreatine]/[creatine] ratio (from 1.8 to 0.8) observed during transition from rest to high workload. Analysis of our data showed that an increase in the flux via creatine kinase is correlated with an increase in the rate of ATP synthesis with a linearity coefficient higher than 1.0. These data are more consistent with the concept of energy channeling by phosphocreatine shuttle than with that of the creatine kinase equilibrium in the heart.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine

Related Publications

V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
October 1998, The American journal of physiology,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
May 2002, The Journal of biological chemistry,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
April 1996, Journal of muscle research and cell motility,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
November 1983, The Journal of surgical research,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
July 1989, Magnetic resonance in medicine,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
November 1982, Biochimica et biophysica acta,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
March 1985, The Journal of biological chemistry,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
September 1992, The American journal of physiology,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
January 1992, Biochimica et biophysica acta,
V V Kupriyanov, and A Ya Steinschneider, and E K Ruuge, and V I Kapel'ko, and M Yu Zueva, and V L Lakomkin, and V N Smirnov, and V A Saks
July 1999, The American journal of physiology,
Copied contents to your clipboard!